Rocco, Danilo <br/><br/>
First-line treatment of advanced non-small cell lung cancer with ALK rearrangement: state of the art and future development.  [electronic resource] 

 -  Expert review of respiratory medicine  03 2022 
 - 315-321 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1747-6356 
<br/><br/><label>Standard No.: </label>10.1080/17476348.2019.1600824  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Drug Resistance, Neoplasm--genetics<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Protein Kinase Inhibitors--adverse effects<br/>Receptor Protein-Tyrosine Kinases--genetics